
NTI | bio, RAND Advance AIxBio Safety During Paris AI Action Summit
The official side event focused on safeguarding capabilities at the convergence of AI with the life sciences.
NTI | bio convened more than 25 high-level biosecurity professionals, AI experts, and policymakers for the inaugural meeting of the International AI-Bio Forum. Participants included representatives from industry, such as Anthropic and Google DeepMind, experts from China, India, Nigeria, the U.K., the U.S., and representatives from multilateral institutions. The virtual meeting was held on April 10-11 and focused on defining the scope, institutional structure, and initial priorities of the International AI-Bio Forum to position it for success in reducing risks associated with rapidly advancing AI-enabled capabilities to engineering living systems.
Meeting participants voiced support for the International AI-Bio Forum, noting the current lack of a global platform to share best practices and coordinate efforts to reduce risks at the intersection of AI and the life sciences. Participants also stressed the importance of international cooperation on developing effective guardrails, including by involving countries without advanced AI capabilities. As one participant noted: “The benefits of AI will take investment to realize, but the risks will come for free.”
The work of the International AI-Bio Forum builds on a key recommendation from a recent NTI | bio report, “The Convergence of Artificial Intelligence and the Life Sciences.” Based on feedback from the recent meeting, the AI-Bio Forum will:
NTI | bio will continue to work with experts in the field to scope the new International AI-Bio Forum and identify key research and development priorities. Rapidly evolving AI capabilities underscore the need to establish the AI-Bio Forum quickly, while working to build a strong international coalition to advance lasting solutions that can be implemented in countries around the world. The next meeting of the Forum will take place in early June as part of NTI’s annual Biosecurity Innovation and Risk Reduction Initiative.
Sign up for our newsletter to get the latest on nuclear and biological threats.
The official side event focused on safeguarding capabilities at the convergence of AI with the life sciences.
To reduce biosecurity risks that arise at the intersection of AI and the life sciences, NTI | bio convened experts in synthetic biology, machine learning, bioinformatics, and international security policy to outline steps toward establishing an international AI-Bio Forum.
NTI | bio’s Dr. Aparupa Sengupta joined a groundbreaking discussion on the nexus of cyber- and bio-security.